[Primary headache - risk factor or comorbid pathology in cognitive impairment]

Area of Science:

• Neurology
• Neuroscience
• Pathophysiology

Background:

• The link between headache and dementia extends beyond mere comorbidity.
• Both primary headache disorders and cognitive impairment exhibit a strong correlation in severity.

Purpose of the Study:

• To explore the common pathophysiological mechanisms linking primary headaches and cognitive impairment.
• To investigate the therapeutic potential of NMDA receptor antagonists in managing both conditions.

Main Methods:

• Review of current literature on headache pathophysiology and dementia.
• Analysis of the role of NMDA receptor activity in both conditions.
• Examination of memantine's effects on cognitive decline and headache symptoms.

Main Results:

• Shared pathophysiological pathways, particularly involving NMDA receptor excitotoxicity, are identified.
• Antinociceptive changes in headaches and glutamate excitotoxicity in dementia are interdependent.
• Memantine demonstrates efficacy in slowing cognitive decline and reducing headache frequency and severity.

Conclusions:

• The interdependence of primary headaches and dementia suggests common underlying mechanisms.
• NMDA receptor antagonists, such as memantine, represent a promising therapeutic target for both neurological conditions.